Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Maintenance After High-Dose Melphalan in Multiple Myeloma
NCT00003007Phase 2Completed
- Sponsor
- University of Tennessee
- Start
- Jul 1996
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of interferon alfa-2b in multiple myeloma (MM), sponsored by University of Tennessee. Primary endpoint: Effectiveness of interferon alfa-2b maintenance. Started Jul 1996; status: completed.
02
Drugs
interferon alfa-2b
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00003007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003007.